Submission Details

Submitter:

Classification:
Definitive
GENCC:100001
Gene:
Disease:
Fraser syndrome 3
Mode Of Inheritance:
Autosomal recessive
Evaluated Date:
03/14/2023
Evidence/Notes:

Glutamate Receptor Interacting Protein 1 (GRIP1; MIM#604597) is a scaffolding protein that interacts with FRAS1/FREM protein complexes and required for their localization. The first report of GRIP1 in association with Fraser syndrome 3 was in Vogel, et.al 2012 (PMID:22510445), which reported in 2 independent fetuses with homozygous loss of function GRIP1 variants and phenotypes consistent with Fraser syndrome. Biallelic or homozygous loss of function (nonsense, frameshift, canonical splice, and deletion) variants in GRIP1 have since been reported in multiple additional affected individuals in the literature with Fraser Syndrome 3 (PMIDs:24357607, 33709629). The mechanism for GRIP1 in association with Fraser Syndrome 3 is loss of function and it is inherited in an autosomal recessive pattern. GRIP1 knockout mouse models have variable background dependent phenotypes including embryonic lethality with severe bullous disorder, haemorrhagic bullae, limb malformations including syndactyly and polydactyly, uni- or bilateral cryptophthalmos, and absent kidneys (PMIDs:11983858, 14730302). GRIP1 localization studies in mouse and in vitro models demonstrate the presence of GRIP1 at the basal cell layer in developing epidermis and co-localization with Fras1 and Frem2 in epithelial cells (PMID:11983858, 14730302). Given the genetic and functional evidence, GRIP1 is classified as Definitive for Fraser Syndrome 3. Of note, missense variants in GRIP1 have also been implicated in Congential Anomalies of the Kidney and Urinary Tract (CAKUT) (PMID:24700879, 26489027, 26539891, 33226606), however curation of GRIP1 for CAKUT and associated phenotypes is out of the scope of the Prenatal Gene Curation Expert Panel.

PubMed IDs:
11983858 14730302 22510445 24357607 33709629
Public Report:
Assertion Criteria:
Submitter Submitted Date:
12/05/2025

The GenCC data are available free of restriction under a CC0 1.0 Universal (CC0 1.0) Public Domain Dedication. The GenCC requests that you give attribution to GenCC and the contributing sources whenever possible and appropriate. The accepted Flagship manuscript is now available from Genetics in Medicine (https://www.gimjournal.org/article/S1098-3600(22)00746-8/fulltext).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. The GenCC does not independently verify the submitted information. Though the information is obtained from sources believed to be reliable, no warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, reliability or usefulness of any information. This disclaimer applies to both isolated and aggregate uses of the information. The information is provided on an "as is" basis, collected through periodic submission and therefore may not represent the most up-to-date information from the submitters. If you have questions about the medical relevance of information contained on this website, please see a healthcare professional; if you have questions about specific gene-disease claims, please contact the relevant sources; and if you have questions about the representation of the data on this website, please contact gencc@thegencc.org.